KR100542468B1 - 페린도프릴의 신규 염 및 이를 함유하는 약제학적 조성물 - Google Patents
페린도프릴의 신규 염 및 이를 함유하는 약제학적 조성물 Download PDFInfo
- Publication number
- KR100542468B1 KR100542468B1 KR1020030017434A KR20030017434A KR100542468B1 KR 100542468 B1 KR100542468 B1 KR 100542468B1 KR 1020030017434 A KR1020030017434 A KR 1020030017434A KR 20030017434 A KR20030017434 A KR 20030017434A KR 100542468 B1 KR100542468 B1 KR 100542468B1
- Authority
- KR
- South Korea
- Prior art keywords
- perindopril
- salts
- salt
- pharmaceutical compositions
- arginine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Description
조건 6개월 | 페린도프릴의 3차-부틸아민 염 잔여 퍼센트(%) | 페린도프릴의 아르기닌 염 잔여 퍼센트(%) |
25℃ 60% R.H. | 101.0 | 99.5 |
30℃ 60% R.H. | 94.4 | 98.1 |
40℃ 75% R.H. | 67.2 | 98.6 |
Claims (5)
- 페린도프릴의 아르기닌 염 및 이의 수화물.
- 1종 이상의 약제학적으로 허용되는 부형제와 함께, 활성 성분으로서 페린도프릴의 아르기닌 염 또는 이의 수화물을 포함하는 약제학적 조성물.
- 제 2항에 있어서, 속방형 정제의 형태로 제공됨을 특징으로 하는 약제학적 조성물.
- 제 2항 또는 제 3항에 있어서, 페린도프릴의 아르기닌 염을 0.2 내지 10 mg 함유함을 특징으로 하는 약제학적 조성물.
- 제 2항 또는 제 3 항에 있어서, 고혈압 및 심부전을 치료하기 위한 약제를 제조하는 데에 사용됨을 특징으로 하는 약제학적 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0204847A FR2838648B1 (fr) | 2002-04-18 | 2002-04-18 | Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent |
FR02.04847 | 2002-04-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030082902A KR20030082902A (ko) | 2003-10-23 |
KR100542468B1 true KR100542468B1 (ko) | 2006-01-11 |
Family
ID=8871521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030017434A KR100542468B1 (ko) | 2002-04-18 | 2003-03-20 | 페린도프릴의 신규 염 및 이를 함유하는 약제학적 조성물 |
Country Status (38)
Country | Link |
---|---|
US (1) | US6696481B2 (ko) |
EP (1) | EP1354873B1 (ko) |
JP (1) | JP3737488B2 (ko) |
KR (1) | KR100542468B1 (ko) |
CN (1) | CN1211365C (ko) |
AP (1) | AP1787A (ko) |
AR (1) | AR039428A1 (ko) |
AT (1) | ATE271036T1 (ko) |
AU (2) | AU2003222921A1 (ko) |
BR (1) | BR0300709A (ko) |
CA (1) | CA2423825C (ko) |
CR (1) | CR7576A (ko) |
DE (1) | DE60300011T2 (ko) |
DK (1) | DK1354873T3 (ko) |
EA (1) | EA005676B1 (ko) |
EC (1) | ECSP045441A (ko) |
ES (1) | ES2224092T3 (ko) |
FR (1) | FR2838648B1 (ko) |
GE (1) | GEP20074211B (ko) |
HK (1) | HK1057367A1 (ko) |
HR (1) | HRP20041079B1 (ko) |
IL (1) | IL164424A (ko) |
IS (1) | IS2842B (ko) |
MA (1) | MA27115A1 (ko) |
ME (1) | ME00454B (ko) |
MX (1) | MXPA03002346A (ko) |
NO (1) | NO324323B1 (ko) |
NZ (1) | NZ524478A (ko) |
OA (1) | OA12806A (ko) |
PL (1) | PL359321A1 (ko) |
PT (1) | PT1354873E (ko) |
RS (1) | RS51694B (ko) |
SI (1) | SI1354873T1 (ko) |
TN (1) | TNSN04206A1 (ko) |
TR (1) | TR200401793T4 (ko) |
UA (1) | UA79463C2 (ko) |
WO (1) | WO2003087050A2 (ko) |
ZA (1) | ZA200301395B (ko) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2395195A (en) * | 2002-11-18 | 2004-05-19 | Cipla Ltd | Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors |
DK1729739T3 (en) * | 2004-03-29 | 2016-10-31 | Servier Lab | PROCESS FOR THE PREPARATION OF A solid pharmaceutical composition. |
SI21800A (sl) | 2004-05-14 | 2005-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze perindoprila |
ATE409036T1 (de) * | 2005-01-06 | 2008-10-15 | Ipca Lab Ltd | Verfahren zur synthese von (2s,3as,7as)-1-(s)- alanyl-octahydro-1h-2-carbonsäurederivaten und verwendung in der synthese von perindopril |
ES2329923T3 (es) * | 2005-03-14 | 2009-12-02 | Les Laboratoires Servier | Procedimiento mejorado para la purificacion de perindopril. |
FR2894825B1 (fr) * | 2005-12-21 | 2010-12-03 | Servier Lab | Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent |
FR2897866B1 (fr) * | 2006-02-28 | 2008-04-18 | Servier Lab | Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2897865B1 (fr) * | 2006-02-28 | 2008-04-18 | Servier Lab | Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
SI22542A (sl) * | 2007-06-04 | 2008-12-31 | Diagen D.O.O. | Stabilna formulacija amorfnih soli perindoprila, postopek za njeno pripravo v industrijskem merilu in njena uporaba za zdravljenje hipertenzije |
WO2009157018A2 (en) | 2008-06-24 | 2009-12-30 | Matrix Laboratories Ltd | Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof |
AU2009212902A1 (en) * | 2008-09-03 | 2010-03-18 | Apotex Pharmachem Inc. | Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof |
CN101766598A (zh) * | 2008-12-31 | 2010-07-07 | 东英(江苏)药业有限公司 | 含有培哚普利的药物组合物 |
GB0910692D0 (en) * | 2009-06-20 | 2009-08-05 | Teva Pharma | Compound |
SI23149A (sl) | 2009-09-21 | 2011-03-31 | Silverstone Pharma | Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni |
FR2961105B1 (fr) * | 2010-06-15 | 2013-02-08 | Servier Lab | Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque |
FR2985512B1 (fr) | 2012-01-05 | 2014-06-20 | Servier Lab | Procede de preparation du sel de l-arginine du perindopril |
FR2985511B1 (fr) | 2012-01-05 | 2014-01-03 | Servier Lab | Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
CN103172696B (zh) * | 2012-12-19 | 2014-12-17 | 宁波美诺华药业股份有限公司 | 一种γ晶型的培哚普利精氨酸盐的制备方法 |
FR3040303B1 (fr) * | 2015-08-27 | 2019-04-05 | Les Laboratoires Servier Suivi Par Sabine Goudeau-Wenger | Composition pharmaceutique comprenant un inhibiteur de la hmg-coa reductase et un inhibiteur eca |
FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
EP3842035A1 (en) | 2019-12-23 | 2021-06-30 | KRKA, d.d., Novo mesto | Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules |
SI26268A (sl) | 2021-11-18 | 2023-05-31 | Zupet Rok | Postopek za pripravo hidratirane oblike perindopril l-arginina |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2503155A2 (fr) * | 1980-10-02 | 1982-10-08 | Science Union & Cie | Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
FR2811320B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
-
2002
- 2002-04-18 FR FR0204847A patent/FR2838648B1/fr not_active Expired - Lifetime
-
2003
- 2003-02-17 GE GEAP8501A patent/GEP20074211B/en unknown
- 2003-02-17 AP APAP/P/2004/003154A patent/AP1787A/en active
- 2003-02-17 PT PT03290383T patent/PT1354873E/pt unknown
- 2003-02-17 DE DE60300011T patent/DE60300011T2/de not_active Expired - Lifetime
- 2003-02-17 ME MEP-2008-688A patent/ME00454B/me unknown
- 2003-02-17 EP EP03290383A patent/EP1354873B1/fr not_active Expired - Lifetime
- 2003-02-17 AT AT03290383T patent/ATE271036T1/de active
- 2003-02-17 ES ES03290383T patent/ES2224092T3/es not_active Expired - Lifetime
- 2003-02-17 DK DK03290383T patent/DK1354873T3/da active
- 2003-02-17 OA OA1200400279A patent/OA12806A/en unknown
- 2003-02-17 WO PCT/FR2003/000507 patent/WO2003087050A2/fr active Application Filing
- 2003-02-17 SI SI200330002T patent/SI1354873T1/xx unknown
- 2003-02-17 TR TR2004/01793T patent/TR200401793T4/xx unknown
- 2003-02-17 AU AU2003222921A patent/AU2003222921A1/en not_active Abandoned
- 2003-02-17 UA UA20041109440A patent/UA79463C2/uk unknown
- 2003-02-17 RS YU90904A patent/RS51694B/en unknown
- 2003-02-20 ZA ZA200301395A patent/ZA200301395B/xx unknown
- 2003-02-21 US US10/371,865 patent/US6696481B2/en not_active Expired - Lifetime
- 2003-02-24 NO NO20030849A patent/NO324323B1/no not_active IP Right Cessation
- 2003-02-27 AU AU2003200700A patent/AU2003200700C1/en not_active Revoked
- 2003-02-28 NZ NZ524478A patent/NZ524478A/en not_active IP Right Cessation
- 2003-03-07 CN CNB031071481A patent/CN1211365C/zh not_active Expired - Lifetime
- 2003-03-18 MX MXPA03002346A patent/MXPA03002346A/es active IP Right Grant
- 2003-03-20 KR KR1020030017434A patent/KR100542468B1/ko active IP Right Grant
- 2003-03-21 BR BR0300709-0A patent/BR0300709A/pt not_active Application Discontinuation
- 2003-03-24 PL PL03359321A patent/PL359321A1/xx not_active Application Discontinuation
- 2003-03-25 JP JP2003083250A patent/JP3737488B2/ja not_active Expired - Lifetime
- 2003-04-03 EA EA200300334A patent/EA005676B1/ru unknown
- 2003-04-03 CA CA002423825A patent/CA2423825C/fr not_active Expired - Fee Related
- 2003-04-16 AR ARP030101332A patent/AR039428A1/es not_active Application Discontinuation
-
2004
- 2004-01-10 HK HK04100189A patent/HK1057367A1/xx not_active IP Right Cessation
- 2004-10-05 IL IL164424A patent/IL164424A/en active IP Right Grant
- 2004-10-15 TN TNP2004000206A patent/TNSN04206A1/en unknown
- 2004-10-27 IS IS7516A patent/IS2842B/is unknown
- 2004-11-03 MA MA27926A patent/MA27115A1/fr unknown
- 2004-11-17 HR HRP20041079AA patent/HRP20041079B1/hr not_active IP Right Cessation
- 2004-11-18 EC EC2004005441A patent/ECSP045441A/es unknown
- 2004-11-18 CR CR7576A patent/CR7576A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100542468B1 (ko) | 페린도프릴의 신규 염 및 이를 함유하는 약제학적 조성물 | |
CA1119177A (en) | Compounds and method for alleviating angiotensin related hypertension | |
AU2009202389B2 (en) | Perindopril | |
EP0710653B1 (en) | Salts of nefazodone having improved dissolution rates | |
EP0272671A2 (en) | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | |
KR20010052557A (ko) | 산화마그네슘을 사용한, ace 억제제 함유 조성물의안정화 | |
CA2422871A1 (en) | Stable solid dosage forms of amino acids and processes for producing same | |
CA1265818A (en) | Nonaromatic fluoroallylamine mao inhibitors | |
US20090099370A1 (en) | Crystalline Form of Perindopril Erbumine | |
NO336460B1 (no) | Fast hurtigdispergerings-doseringsform inneholdende substituerte imidazolderivater | |
HU210679B (en) | Process for producing new tetrahydro-pyrido/3,4-b/indol derivatives and pharmaceutical compositions containing the same | |
HU207047B (en) | Process for producing new pyridine derivatives and pharmaceutical copositions comprising same | |
JPH06220081A (ja) | アスコルビン酸−2−O−α−グルコシドの金属塩およびその医薬用途 | |
JP7137677B2 (ja) | 水性組成物(さん) | |
HU211089B (en) | Process for preparing naphto-thiazole derivatives and pharmaceutical compositions containing them | |
MXPA99002118A (en) | Crystalline pharmaceutical product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121207 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20131028 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20141126 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20151106 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20161028 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20171102 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20181115 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20191202 Year of fee payment: 15 |